Antibiotic resistance Infections and Infestations
Conditions
Interventions
Randomized comparison of artificial intelligence–clinical decision support system (AI-CDSS) use with standard diagnostic and prescribing practices for MRSA.
This randomized controlled trial compares
Sponsors
Tri-Service General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Medical Licensure Requirements: Participants must be licensed healthcare providers authorized to prescribe antibiotics, including residents, fellows, and attending physicians. 2. Clinical Experience: Participants must have at least one year of clinical experience to ensure they are familiar with antibiotic prescribing practices. 3. Technology Access: Participants must have regular access to computers or tablets with internet connectivity to use the AI clinical decision support system. 4. Training Commitment: Participants must be willing to complete a brief training session to learn how to properly use the AI system.
Exclusion criteria
Exclusion criteria: 1. Limited Prescribing Authority: Healthcare practitioners without medication prescribing privileges, such as nurses, medical interns, and medical students. 2. Insufficient Clinical Experience: Healthcare providers with less than one year of clinical practice experience.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physicians' confidence in diagnosing and managing MRSA infections, including the identification of PVL-positive strains, will be rated by physicians for each case. Confidence will be measured using a structured questionnaire on days 3, 5, 7, and 14 after antibiotic treatment initiation. | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures will be measured using a questionnaire on days 3, 5, 7, and 14 after antibiotic treatment initiation: 1. Satisfaction with the diagnostic and prescribing process, including factors influencing satisfaction, decision-making efficiency (time required and ease of accessing molecular information), and reliance on technological tools for MRSA management, are all rated and reported by physicians. 2. The effectiveness of diagnostic-guided treatment choices in mitigating public health concerns related to antibiotic resistance and PVL-associated virulence will be assessed by physicians. | — |
Countries
Taiwan
Contacts
Public ContactHung-Sheng Shang
Outcome results
None listed